Icon

PARLODEL (nda017962)- (EQ 5MG BASE)

BROMOCRIPTINE MESYLATE SS PHARMA
EQ 5MG BASE
No No
Expired Expired
None None
None No
Parlodel (bromocriptine mesylate) is indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. Parlodel treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. Parlodel therapy is indicated in the treatment of acromegaly. Parlodel SnapTabs or capsules are indicated in the treatment of the signs and symptoms of idiopathic or postencephalitic Parkinson’s disease.
2 0 2
Total Other Developers None
Drugs with Suitability No
EQ 5MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ******** ***** ******* *********** **.**. ***/*, ***/*, ***, ***/*, ********** *******, ********-************* ******, *******-********** ********, ********* ******, ***** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.